Biomarker SOPs: Getting Optimum Value from Your Biomarker Programs

Ken Rubenstein, PhD
 

Biomarkers Survey Questions
1. Please classify your organization.
2. Please identify your position.
3. In which stage(s) of work are you involved?
4. In what area(s) of research are you involved?
5. At what level(s) is your organization involved with biomarker planning and discovery?
6. Please choose 1 or more of the options that apply to your organization:
Supports precommercial, collaborative biomarker development/validation
Does not support precommercial, collaborative biomarker development/validation
Expects to be a member of the NIH/FDA/PhRMA Biomarkers Consortium
Does not expect to be a member
7. What is your organization’s view toward SOPs or guidelines for biomarker development?
8. What is your organization’s position on outsourcing biomarker discovery and development?
9. If your organization does any biomarker outsourcing, why? (multiple answers OK)
10. What type(s) of biomarkers does your organization use?
11. In what stage(s) does your organization use biomarkers?
12. What are the plans for your organization’s budget for biomarker-related work for fiscal 2007?
13. What are the plans for your organization’s budget for biomarker-related work for the next 3 years?